These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 31213201)

  • 1. Proteasome: a Nanomachinery of Creative Destruction.
    Kudriaeva AA; Belogurov AA
    Biochemistry (Mosc); 2019 Jan; 84(Suppl 1):S159-S192. PubMed ID: 31213201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nuclear ubiquitin-proteasome system: visualization of proteasomes, protein aggregates, and proteolysis in the cell nucleus.
    von Mikecz A; Chen M; Rockel T; Scharf A
    Methods Mol Biol; 2008; 463():191-202. PubMed ID: 18951170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ubiquitin-independent protein degradation in proteasomes].
    Buneeva OA; Medvedev AE
    Biomed Khim; 2018 Mar; 64(2):134-148. PubMed ID: 29723144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-canonical ubiquitin-based signals for proteasomal degradation.
    Kravtsova-Ivantsiv Y; Ciechanover A
    J Cell Sci; 2012 Feb; 125(Pt 3):539-48. PubMed ID: 22389393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unstructured Biology of Proteins from Ubiquitin-Proteasome System: Roles in Cancer and Neurodegenerative Diseases.
    Gadhave K; Kumar P; Kapuganti SK; Uversky VN; Giri R
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32455657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteasomal degradation of damaged polyubiquitin.
    Inobe T; Nozaki M
    Biochem Biophys Res Commun; 2016 Feb; 471(1):34-40. PubMed ID: 26851366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim?
    Dennissen FJ; Kholod N; van Leeuwen FW
    Prog Neurobiol; 2012 Feb; 96(2):190-207. PubMed ID: 22270043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K63 ubiquitylation triggers proteasomal degradation by seeding branched ubiquitin chains.
    Ohtake F; Tsuchiya H; Saeki Y; Tanaka K
    Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1401-E1408. PubMed ID: 29378950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitination and deubiquitination: Implications on cancer therapy.
    Dagar G; Kumar R; Yadav KK; Singh M; Pandita TK
    Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194979. PubMed ID: 37633647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein damage, repair and proteolysis.
    Chondrogianni N; Petropoulos I; Grimm S; Georgila K; Catalgol B; Friguet B; Grune T; Gonos ES
    Mol Aspects Med; 2014 Feb; 35():1-71. PubMed ID: 23107776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ubiquitin-proteasome pathway as a target for therapeutic strategies].
    Staszczak M
    Postepy Biochem; 2017; 63(4):287-303. PubMed ID: 29374430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro analysis of proteasome-associated USP14 activity for substrate degradation and deubiquitylation.
    Muniyappan S; Lee BH
    Methods Enzymol; 2019; 619():249-268. PubMed ID: 30910023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complexity of recognition of ubiquitinated substrates by the 26S proteasome.
    Ciechanover A; Stanhill A
    Biochim Biophys Acta; 2014 Jan; 1843(1):86-96. PubMed ID: 23872423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
    Ciechanover A; Kwon YT
    Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the ubiquitin-proteasome system in brain ischemia: friend or foe?
    Caldeira MV; Salazar IL; Curcio M; Canzoniero LM; Duarte CB
    Prog Neurobiol; 2014 Jan; 112():50-69. PubMed ID: 24157661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration.
    Deger JM; Gerson JE; Kayed R
    Aging Cell; 2015 Oct; 14(5):715-24. PubMed ID: 26053162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulating the Ubiquitin-Proteasome System: A Therapeutic Strategy for Autoimmune Diseases.
    Yadav D; Lee JY; Puranik N; Chauhan PS; Chavda V; Jin JO; Lee PCW
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ubiquitin-proteasome system in retinal health and disease.
    Campello L; Esteve-Rudd J; Cuenca N; Martín-Nieto J
    Mol Neurobiol; 2013 Apr; 47(2):790-810. PubMed ID: 23339020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein oxidative modification in the aging organism and the role of the ubiquitin proteasomal system.
    Kastle M; Grune T
    Curr Pharm Des; 2011 Dec; 17(36):4007-22. PubMed ID: 22188451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pupylation as a signal for proteasomal degradation in bacteria.
    Striebel F; Imkamp F; Özcelik D; Weber-Ban E
    Biochim Biophys Acta; 2014 Jan; 1843(1):103-13. PubMed ID: 23557784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.